Anand K. Parekh

Internal Medicine
38135 Market Square Dr
Ste 109
Zephyrhills, FL 33542

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Journal: Annals of internal medicine
Published: June 29, 2026

The Obesity Epidemic at a Crossroads: Progress and Pitfalls.

The Obesity Epidemic at a Crossroads: Progress and Pitfalls.

Journal: JAMA
Published: May 20, 2026

Validation of a Mucosal IgA Assay for SARS-CoV-2.

Validation of a Mucosal IgA Assay for SARS-CoV-2.

Journal: Microorganisms
Published: March 24, 2026

Fuelling prevention: federal levers to integrate nutrition into primary care.

Fuelling prevention: federal levers to integrate nutrition into primary care.

Journal: Health affairs scholar
Published: December 04, 2025

Resuming the Decline in Cardiovascular Deaths: Urgent Federal Policy Actions.

Resuming the Decline in Cardiovascular Deaths: Urgent Federal Policy Actions.

Journal: Circulation. Cardiovascular quality and outcomes
Published: September 09, 2025

Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform-specific priming and immune imprinting.

Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform-specific priming and immune imprinting.

Journal: The Journal of infection
Published: March 17, 2025

A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine.

A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine.

Journal: Microorganisms
Published: October 09, 2024

Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines.

Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines.

Journal: medRxiv : the preprint server for health sciences
Published: January 31, 2024

Four Defining Health Issues of the 2024 Presidential Election.

Four Defining Health Issues of the 2024 Presidential Election.

Journal: JAMA
Published: January 25, 2024

Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccines.

Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccines.

Journal: The Journal of infection
Published: January 18, 2024

A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection.

A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection.

Journal: Microorganisms
Published: June 01, 2023

Optimizing US Global Health Funding.

Optimizing US Global Health Funding.

Journal: JAMA
Published: March 30, 2023
Showing 1-12 of 35

Last Updated: 09/26/2026